Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Epstein

Showing results (831-840 of 1,132) with videos related to

Pageof 114
Sort By:
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of potentiated antibodies to morphine on behavioral reactions in rats with morphine dependenceT M Vorob'eva, O G Berchenko, V V Geiko, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Experimental study of antiblastic activity in potentiated antibodies to tumor necrosis factor-alphaE N Amosova, E P Zueva, T G Razina, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of the offspringT G Borovskaya, O P Loskutova, E V Abramova, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Analgesic and antiinflammatory activity of antibodies to histamine under experimental conditionsS G Krylova, T G Razina, E P Zueva, et al.
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostateRobert W Veltri, Masood A Khan, M Craig Miller, et al.
Bulletin of Experimental Biology and Medicine|August 15, 2009
Mutagenic activity of potentiated antibodies to erythropoietinO L Voronova, O P Rogozina, Yu L Dugina, et al.
Oncotarget|February 5, 2017
Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratificationFelix M Chinea, Kirill Lyapichev, Jonathan I Epstein, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 14, 2016
[Antiamnesic effects divaza and its component model β-amyloid amnesia]K K Ganinа, Yu L Duginа, E S Zhavbert, et al.
Urology|November 24, 1999
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomyS R Potter, M C Miller, L A Mangold, et al.
Pageof 114

Showing results (831-840 of 1,132) with videos related to

Sort By:
Pageof 114
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of potentiated antibodies to morphine on behavioral reactions in rats with morphine dependenceT M Vorob'eva, O G Berchenko, V V Geiko, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Experimental study of antiblastic activity in potentiated antibodies to tumor necrosis factor-alphaE N Amosova, E P Zueva, T G Razina, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Effect of ultralow doses of antibodies to erythropoietin on antenatal and postnatal development of the offspringT G Borovskaya, O P Loskutova, E V Abramova, et al.
Bulletin of Experimental Biology and Medicine|September 2, 2003
Analgesic and antiinflammatory activity of antibodies to histamine under experimental conditionsS G Krylova, T G Razina, E P Zueva, et al.
Urology|June 19, 2007
Updated nomogram to predict pathologic stage of prostate cancer given prostate-specific antigen level, clinical stage, and biopsy Gleason score (Partin tables) based on cases from 2000 to 2005Danil V Makarov, Bruce J Trock, Elizabeth B Humphreys, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 27, 2004
Ability to predict metastasis based on pathology findings and alterations in nuclear structure of normal-appearing and cancer peripheral zone epithelium in the prostateRobert W Veltri, Masood A Khan, M Craig Miller, et al.
Bulletin of Experimental Biology and Medicine|August 15, 2009
Mutagenic activity of potentiated antibodies to erythropoietinO L Voronova, O P Rogozina, Yu L Dugina, et al.
Oncotarget|February 5, 2017
Understanding PSA and its derivatives in prediction of tumor volume: Addressing health disparities in prostate cancer risk stratificationFelix M Chinea, Kirill Lyapichev, Jonathan I Epstein, et al.
Zhurnal Nevrologii I Psikhiatrii Imeni S.S. Korsakova|October 14, 2016
[Antiamnesic effects divaza and its component model β-amyloid amnesia]K K Ganinа, Yu L Duginа, E S Zhavbert, et al.
Urology|November 24, 1999
Genetically engineered neural networks for predicting prostate cancer progression after radical prostatectomyS R Potter, M C Miller, L A Mangold, et al.
Pageof 114